These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30182144)

  • 1. Discovery of novel wee1 inhibitors via structure-based virtual screening and biological evaluation.
    Li Y; Pu Y; Liu H; Zhang L; Liu X; Li Y; Zuo Z
    J Comput Aided Mol Des; 2018 Sep; 32(9):901-915. PubMed ID: 30182144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadening the scope of WEE1 inhibitors: identifying novel drug candidates via computational approaches and drug repurposing.
    Chandrasekaran J; Sivakumaresan Y; Shankar K; Dickson M; Laya Saravana Kumar S; Ramanathan L; Ahmad I; Patel H
    J Biomol Struct Dyn; 2024 Nov; 42(18):9337-9347. PubMed ID: 37632319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ensemble docking-based virtual screening toward identifying inhibitors against Wee1 kinase.
    Li Y; Wu DM; Kong LM; Zhang S; Du H; Sun W; Zhang L; Li Y; Zuo Z
    Future Med Chem; 2019 Aug; 11(15):1889-1906. PubMed ID: 31517534
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of Potent Pyrazolopyrimidinone-Based WEE1 Inhibitors with Limited Single-Agent Cytotoxicity for Cancer Therapy.
    Matheson CJ; Casalvieri KA; Backos DS; Reigan P
    ChemMedChem; 2018 Aug; 13(16):1681-1694. PubMed ID: 29883531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprocessing of protein-ligand docking poses using linear response MM-PB/SA: application to Wee1 kinase inhibitors.
    Wichapong K; Lawson M; Pianwanit S; Kokpol S; Sippl W
    J Chem Inf Model; 2010 Sep; 50(9):1574-88. PubMed ID: 20712342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.
    Sharma A; Thelma BK
    J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase Wee1. Structure-activity relationships for chromophore modification and phenyl ring substitution.
    Palmer BD; Thompson AM; Booth RJ; Dobrusin EM; Kraker AJ; Lee HH; Lunney EA; Mitchell LH; Ortwine DF; Smaill JB; Swan LM; Denny WA
    J Med Chem; 2006 Aug; 49(16):4896-911. PubMed ID: 16884302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors.
    Zhu JY; Cuellar RA; Berndt N; Lee HE; Olesen SH; Martin MP; Jensen JT; Georg GI; Schönbrunn E
    J Med Chem; 2017 Sep; 60(18):7863-7875. PubMed ID: 28792760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent inhibitors for interleukin-2-inducible T-cell kinase: structure-based virtual screening and molecular dynamics simulation approaches.
    Meganathan C; Sakkiah S; Lee Y; Narayanan JV; Lee KW
    J Mol Model; 2013 Feb; 19(2):715-26. PubMed ID: 23015102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting WEE1 Kinase in Cancer.
    Matheson CJ; Backos DS; Reigan P
    Trends Pharmacol Sci; 2016 Oct; 37(10):872-881. PubMed ID: 27427153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Flavonoids as Putative ROS-1 Kinase Inhibitors Using Pharmacophore Modeling for NSCLC Therapeutics.
    Parate S; Kumar V; Hong JC; Lee KW
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33917039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico identification of putative bifunctional Plk1 inhibitors by integrative virtual screening and structural dynamics approach.
    Shafique S; Bibi N; Rashid S
    J Theor Biol; 2016 Jan; 388():72-84. PubMed ID: 26493360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a rhodium(iii) complex as a Wee1 inhibitor against TP53-mutated triple-negative breast cancer cells.
    Yang GJ; Zhong HJ; Ko CN; Wong SY; Vellaisamy K; Ye M; Ma DL; Leung CH
    Chem Commun (Camb); 2018 Mar; 54(20):2463-2466. PubMed ID: 29367998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of
    Babu TM; Rammohan A; Baki VB; Devi S; Gunasekar D; Rajendra W
    Drug Des Devel Ther; 2016; 10():3611-3632. PubMed ID: 27853354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations.
    Zhang Y; Zhang TJ; Tu S; Zhang ZH; Meng FH
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32911607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational simulation studies on the binding selectivity of Wee1 and Checkpoint kinase 1 by molecular dynamics simulation combined with free energy calculations.
    Li Y; Liu X; Zhang S; Wang L; Zhang L; Zuo Z
    J Biomol Struct Dyn; 2022 Feb; 40(3):1172-1181. PubMed ID: 33016857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore-based virtual screening, molecular docking, molecular dynamics simulation, and biological evaluation for the discovery of novel BRD4 inhibitors.
    Yan G; Hou M; Luo J; Pu C; Hou X; Lan S; Li R
    Chem Biol Drug Des; 2018 Feb; 91(2):478-490. PubMed ID: 28901664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe.
    De Witt Hamer PC; Mir SE; Noske D; Van Noorden CJ; Würdinger T
    Clin Cancer Res; 2011 Jul; 17(13):4200-7. PubMed ID: 21562035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.